May 2024
1. FERNANDEZ-BRAVO-RODRIGO J, Cavero-Redondo I, Luceron-Lucas-Torres M, Martinez-Garcia I, et al
   Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis.
   Eur J Pharmacol. 2024;976:176702.
   

   >> Share

   
   
2. RUBY HA, Sayed RH, Khattab MA, Sallam NA, et al
   Fenofibrate ameliorates nitroglycerin-induced migraine in rats: Role of CGRP/p-CREB/P2X3 and NGF/PKC/ASIC3 signaling pathways.
   Eur J Pharmacol. 2024;976:176667.
   

   >> Share

   
   March 2022
3. RIBEIRO DOS SANTOS JB, Ribeiro da Silva MR
   Small molecule CGRP receptor antagonists for the preventive treatment of migraine: A review.
   Eur J Pharmacol. 2022 Mar 28:174902. doi: 10.1016/j.ejphar.2022.174902.
   

   >> Share

   
   November 2021
4. NAKAMURA M, Jang IS
   Propranolol modulation of tetrodotoxin-resistant Na(+) channels in dural afferent neurons.
   Eur J Pharmacol. 2021;910:174449.
   

   >> Share

   
   November 2020
5. CHEN SH, Chao CN, Chen SY, Lin HP, et al
   Flunarizine, a drug approved for treating migraine and vertigo, exhibits cytotoxicity in GBM cells.
   Eur J Pharmacol. 2020 Nov 24:173756. doi: 10.1016/j.ejphar.2020.173756.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share